β-Catenin is the nuclear effector of the Wnt signaling cascade. The mechanism by which nuclear activity of β-Catenin is regulated is not very well defined. We identified a cofactor of CRM1-mediated nuclear export, Ran-binding protein 3 (RanBP3) as a novel β-Catenin interacting protein that binds directly to β-Catenin in a RanGTP stimulated manner.
In vivo, RanBP3 inhibits β-Catenin-mediated transcriptional activation both in Wnt1 or β-Catenin stimulated human cells. In Xenopus embryos, RanBP3 interferes with β-Catenin-induced dorsoventral axis formation. Furthermore, RanBP3 depletion stimulates the Wnt pathway, both in human cells and Drosophila embryos. In human cells, this is accompanied by an increase of active β-Catenin in the nucleus. Conversely, overexpression of RanBP3 leads to a shift of active β-Catenin towards the cytoplasm.
Interestingly, RanBP3 only acts on a very small dephosphorylated nuclear fraction of total β-Catenin, that correlates with transcriptional activity. We can visualize this fraction only in certain colon carcinoma cells that contain "massive" amounts of this active β-Catenin; still only a very small fraction of total β-Catenin. We find that modulation of β-Catenin activity and localization by RanBP3 is independent of APC and CRM1.
We conclude that RanBP3 is a direct export enhancer for β-Catenin, independent of its role as a CRM1 associated nuclear export cofactor, and ask -- what is active β-Catenin?
Read more: Terminating Wnt signals: a novel nuclear export mechanism targets activated β-Catenin. Journal of Cell Biology, 2005